Global DTaP and Tdap Vaccines Market Insights and Forecast to 2031

Report ID: 1197239 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 DTaP and Tdap Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global DTaP and Tdap Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 DTaP
        1.2.3 Td
        1.2.4 Tdap
    1.3 Market by Application
        1.3.1 Global DTaP and Tdap Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Adult
        1.3.3 Pediatric
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global DTaP and Tdap Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global DTaP and Tdap Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global DTaP and Tdap Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global DTaP and Tdap Vaccines Sales by Region
        2.4.1 Global DTaP and Tdap Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales DTaP and Tdap Vaccines by Region (2023-2028)
    2.5 Global DTaP and Tdap Vaccines Revenue by Region
        2.5.1 Global DTaP and Tdap Vaccines Revenue by Region (2017-2022)
        2.5.2 Global DTaP and Tdap Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global DTaP and Tdap Vaccines Sales by Manufacturers
        3.1.1 Global Top DTaP and Tdap Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global DTaP and Tdap Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of DTaP and Tdap Vaccines in 2021
    3.2 Global DTaP and Tdap Vaccines Revenue by Manufacturers
        3.2.1 Global DTaP and Tdap Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global DTaP and Tdap Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by DTaP and Tdap Vaccines Revenue in 2021
    3.3 Global DTaP and Tdap Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global DTaP and Tdap Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global DTaP and Tdap Vaccines Sales by Type
        4.1.1 Global DTaP and Tdap Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global DTaP and Tdap Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global DTaP and Tdap Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global DTaP and Tdap Vaccines Revenue by Type
        4.2.1 Global DTaP and Tdap Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global DTaP and Tdap Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global DTaP and Tdap Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global DTaP and Tdap Vaccines Price by Type
        4.3.1 Global DTaP and Tdap Vaccines Price by Type (2017-2022)
        4.3.2 Global DTaP and Tdap Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global DTaP and Tdap Vaccines Sales by Application
        5.1.1 Global DTaP and Tdap Vaccines Historical Sales by Application (2017-2022)
        5.1.2 Global DTaP and Tdap Vaccines Forecasted Sales by Application (2023-2028)
        5.1.3 Global DTaP and Tdap Vaccines Sales Market Share by Application (2017-2028)
    5.2 Global DTaP and Tdap Vaccines Revenue by Application
        5.2.1 Global DTaP and Tdap Vaccines Historical Revenue by Application (2017-2022)
        5.2.2 Global DTaP and Tdap Vaccines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global DTaP and Tdap Vaccines Revenue Market Share by Application (2017-2028)
    5.3 Global DTaP and Tdap Vaccines Price by Application
        5.3.1 Global DTaP and Tdap Vaccines Price by Application (2017-2022)
        5.3.2 Global DTaP and Tdap Vaccines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America DTaP and Tdap Vaccines Market Size by Type
        6.1.1 North America DTaP and Tdap Vaccines Sales by Type (2017-2028)
        6.1.2 North America DTaP and Tdap Vaccines Revenue by Type (2017-2028)
    6.2 North America DTaP and Tdap Vaccines Market Size by Application
        6.2.1 North America DTaP and Tdap Vaccines Sales by Application (2017-2028)
        6.2.2 North America DTaP and Tdap Vaccines Revenue by Application (2017-2028)
    6.3 North America DTaP and Tdap Vaccines Market Size by Country
        6.3.1 North America DTaP and Tdap Vaccines Sales by Country (2017-2028)
        6.3.2 North America DTaP and Tdap Vaccines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe DTaP and Tdap Vaccines Market Size by Type
        7.1.1 Europe DTaP and Tdap Vaccines Sales by Type (2017-2028)
        7.1.2 Europe DTaP and Tdap Vaccines Revenue by Type (2017-2028)
    7.2 Europe DTaP and Tdap Vaccines Market Size by Application
        7.2.1 Europe DTaP and Tdap Vaccines Sales by Application (2017-2028)
        7.2.2 Europe DTaP and Tdap Vaccines Revenue by Application (2017-2028)
    7.3 Europe DTaP and Tdap Vaccines Market Size by Country
        7.3.1 Europe DTaP and Tdap Vaccines Sales by Country (2017-2028)
        7.3.2 Europe DTaP and Tdap Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific DTaP and Tdap Vaccines Market Size by Type
        8.1.1 Asia Pacific DTaP and Tdap Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific DTaP and Tdap Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific DTaP and Tdap Vaccines Market Size by Application
        8.2.1 Asia Pacific DTaP and Tdap Vaccines Sales by Application (2017-2028)
        8.2.2 Asia Pacific DTaP and Tdap Vaccines Revenue by Application (2017-2028)
    8.3 Asia Pacific DTaP and Tdap Vaccines Market Size by Region
        8.3.1 Asia Pacific DTaP and Tdap Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific DTaP and Tdap Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America DTaP and Tdap Vaccines Market Size by Type
        9.1.1 Latin America DTaP and Tdap Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America DTaP and Tdap Vaccines Revenue by Type (2017-2028)
    9.2 Latin America DTaP and Tdap Vaccines Market Size by Application
        9.2.1 Latin America DTaP and Tdap Vaccines Sales by Application (2017-2028)
        9.2.2 Latin America DTaP and Tdap Vaccines Revenue by Application (2017-2028)
    9.3 Latin America DTaP and Tdap Vaccines Market Size by Country
        9.3.1 Latin America DTaP and Tdap Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America DTaP and Tdap Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa DTaP and Tdap Vaccines Market Size by Type
        10.1.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa DTaP and Tdap Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa DTaP and Tdap Vaccines Market Size by Application
        10.2.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa DTaP and Tdap Vaccines Revenue by Application (2017-2028)
    10.3 Middle East and Africa DTaP and Tdap Vaccines Market Size by Country
        10.3.1 Middle East and Africa DTaP and Tdap Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa DTaP and Tdap Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sanofi Pasteur
        11.1.1 Sanofi Pasteur Corporation Information
        11.1.2 Sanofi Pasteur Overview
        11.1.3 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sanofi Pasteur DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi Pasteur Recent Developments
    11.2 GlaxoSmithKline
        11.2.1 GlaxoSmithKline Corporation Information
        11.2.2 GlaxoSmithKline Overview
        11.2.3 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GlaxoSmithKline DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GlaxoSmithKline Recent Developments
    11.3 Protein Sciences Corporation
        11.3.1 Protein Sciences Corporation Corporation Information
        11.3.2 Protein Sciences Corporation Overview
        11.3.3 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Protein Sciences Corporation DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Protein Sciences Corporation Recent Developments
    11.4 Novartis AG
        11.4.1 Novartis AG Corporation Information
        11.4.2 Novartis AG Overview
        11.4.3 Novartis AG DTaP and Tdap Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Novartis AG DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Novartis AG Recent Developments
    11.5 Seqirus
        11.5.1 Seqirus Corporation Information
        11.5.2 Seqirus Overview
        11.5.3 Seqirus DTaP and Tdap Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Seqirus DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Seqirus Recent Developments
    11.6 Merck Sharp & Dohme Corp
        11.6.1 Merck Sharp & Dohme Corp Corporation Information
        11.6.2 Merck Sharp & Dohme Corp Overview
        11.6.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Merck Sharp & Dohme Corp Recent Developments
    11.7 Astellas Pharma US, Inc
        11.7.1 Astellas Pharma US, Inc Corporation Information
        11.7.2 Astellas Pharma US, Inc Overview
        11.7.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Astellas Pharma US, Inc DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Astellas Pharma US, Inc Recent Developments
    11.8 Pfizer Inc
        11.8.1 Pfizer Inc Corporation Information
        11.8.2 Pfizer Inc Overview
        11.8.3 Pfizer Inc DTaP and Tdap Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Pfizer Inc DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Pfizer Inc Recent Developments
    11.9 Johnson & Johnson
        11.9.1 Johnson & Johnson Corporation Information
        11.9.2 Johnson & Johnson Overview
        11.9.3 Johnson & Johnson DTaP and Tdap Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Johnson & Johnson DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Johnson & Johnson Recent Developments
    11.10 Lanzhou Institute of Biological Products Co., Ltd
        11.10.1 Lanzhou Institute of Biological Products Co., Ltd Corporation Information
        11.10.2 Lanzhou Institute of Biological Products Co., Ltd Overview
        11.10.3 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Lanzhou Institute of Biological Products Co., Ltd Recent Developments
    11.11 AstraZeneca
        11.11.1 AstraZeneca Corporation Information
        11.11.2 AstraZeneca Overview
        11.11.3 AstraZeneca DTaP and Tdap Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 AstraZeneca DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 AstraZeneca Recent Developments
    11.12 Emergent BioSolutions Inc
        11.12.1 Emergent BioSolutions Inc Corporation Information
        11.12.2 Emergent BioSolutions Inc Overview
        11.12.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Emergent BioSolutions Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 DTaP and Tdap Vaccines Industry Chain Analysis
    12.2 DTaP and Tdap Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 DTaP and Tdap Vaccines Production Mode & Process
    12.4 DTaP and Tdap Vaccines Sales and Marketing
        12.4.1 DTaP and Tdap Vaccines Sales Channels
        12.4.2 DTaP and Tdap Vaccines Distributors
    12.5 DTaP and Tdap Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 DTaP and Tdap Vaccines Industry Trends
    13.2 DTaP and Tdap Vaccines Market Drivers
    13.3 DTaP and Tdap Vaccines Market Challenges
    13.4 DTaP and Tdap Vaccines Market Restraints
14 Key Findings in The Global DTaP and Tdap Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global DTaP and Tdap Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of DTaP
    Table 3. Major Manufacturers of Td
    Table 4. Major Manufacturers of Tdap
    Table 5. Global DTaP and Tdap Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global DTaP and Tdap Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global DTaP and Tdap Vaccines Sales by Region (2017-2022) & (K Units)
    Table 8. Global DTaP and Tdap Vaccines Sales Market Share by Region (2017-2022)
    Table 9. Global DTaP and Tdap Vaccines Sales by Region (2023-2028) & (K Units)
    Table 10. Global DTaP and Tdap Vaccines Sales Market Share by Region (2023-2028)
    Table 11. Global DTaP and Tdap Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global DTaP and Tdap Vaccines Revenue Market Share by Region (2017-2022)
    Table 13. Global DTaP and Tdap Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global DTaP and Tdap Vaccines Revenue Market Share by Region (2023-2028)
    Table 15. Global DTaP and Tdap Vaccines Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global DTaP and Tdap Vaccines Sales Share by Manufacturers (2017-2022)
    Table 17. Global DTaP and Tdap Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global DTaP and Tdap Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 19. DTaP and Tdap Vaccines Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global DTaP and Tdap Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global DTaP and Tdap Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DTaP and Tdap Vaccines as of 2021)
    Table 22. DTaP and Tdap Vaccines Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers DTaP and Tdap Vaccines Product Offered
    Table 24. Date of Manufacturers Enter into DTaP and Tdap Vaccines Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)
    Table 27. Global DTaP and Tdap Vaccines Sales by Type (2023-2028) & (K Units)
    Table 28. Global DTaP and Tdap Vaccines Sales Share by Type (2017-2022)
    Table 29. Global DTaP and Tdap Vaccines Sales Share by Type (2023-2028)
    Table 30. Global DTaP and Tdap Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global DTaP and Tdap Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global DTaP and Tdap Vaccines Revenue Share by Type (2017-2022)
    Table 33. Global DTaP and Tdap Vaccines Revenue Share by Type (2023-2028)
    Table 34. DTaP and Tdap Vaccines Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global DTaP and Tdap Vaccines Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)
    Table 37. Global DTaP and Tdap Vaccines Sales by Application (2023-2028) & (K Units)
    Table 38. Global DTaP and Tdap Vaccines Sales Share by Application (2017-2022)
    Table 39. Global DTaP and Tdap Vaccines Sales Share by Application (2023-2028)
    Table 40. Global DTaP and Tdap Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global DTaP and Tdap Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global DTaP and Tdap Vaccines Revenue Share by Application (2017-2022)
    Table 43. Global DTaP and Tdap Vaccines Revenue Share by Application (2023-2028)
    Table 44. DTaP and Tdap Vaccines Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global DTaP and Tdap Vaccines Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)
    Table 47. North America DTaP and Tdap Vaccines Sales by Type (2023-2028) & (K Units)
    Table 48. North America DTaP and Tdap Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America DTaP and Tdap Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)
    Table 51. North America DTaP and Tdap Vaccines Sales by Application (2023-2028) & (K Units)
    Table 52. North America DTaP and Tdap Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America DTaP and Tdap Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America DTaP and Tdap Vaccines Sales by Country (2017-2022) & (K Units)
    Table 55. North America DTaP and Tdap Vaccines Sales by Country (2023-2028) & (K Units)
    Table 56. North America DTaP and Tdap Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America DTaP and Tdap Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)
    Table 59. Europe DTaP and Tdap Vaccines Sales by Type (2023-2028) & (K Units)
    Table 60. Europe DTaP and Tdap Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe DTaP and Tdap Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)
    Table 63. Europe DTaP and Tdap Vaccines Sales by Application (2023-2028) & (K Units)
    Table 64. Europe DTaP and Tdap Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe DTaP and Tdap Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe DTaP and Tdap Vaccines Sales by Country (2017-2022) & (K Units)
    Table 67. Europe DTaP and Tdap Vaccines Sales by Country (2023-2028) & (K Units)
    Table 68. Europe DTaP and Tdap Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe DTaP and Tdap Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific DTaP and Tdap Vaccines Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific DTaP and Tdap Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific DTaP and Tdap Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific DTaP and Tdap Vaccines Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific DTaP and Tdap Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific DTaP and Tdap Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific DTaP and Tdap Vaccines Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific DTaP and Tdap Vaccines Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific DTaP and Tdap Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific DTaP and Tdap Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America DTaP and Tdap Vaccines Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America DTaP and Tdap Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America DTaP and Tdap Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America DTaP and Tdap Vaccines Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America DTaP and Tdap Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America DTaP and Tdap Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America DTaP and Tdap Vaccines Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America DTaP and Tdap Vaccines Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America DTaP and Tdap Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America DTaP and Tdap Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa DTaP and Tdap Vaccines Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa DTaP and Tdap Vaccines Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa DTaP and Tdap Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa DTaP and Tdap Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa DTaP and Tdap Vaccines Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa DTaP and Tdap Vaccines Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa DTaP and Tdap Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa DTaP and Tdap Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa DTaP and Tdap Vaccines Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa DTaP and Tdap Vaccines Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa DTaP and Tdap Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa DTaP and Tdap Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Sanofi Pasteur Corporation Information
    Table 107. Sanofi Pasteur Description and Major Businesses
    Table 108. Sanofi Pasteur DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Sanofi Pasteur DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Sanofi Pasteur Recent Developments
    Table 111. GlaxoSmithKline Corporation Information
    Table 112. GlaxoSmithKline Description and Major Businesses
    Table 113. GlaxoSmithKline DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. GlaxoSmithKline DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. GlaxoSmithKline Recent Developments
    Table 116. Protein Sciences Corporation Corporation Information
    Table 117. Protein Sciences Corporation Description and Major Businesses
    Table 118. Protein Sciences Corporation DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Protein Sciences Corporation DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Protein Sciences Corporation Recent Developments
    Table 121. Novartis AG Corporation Information
    Table 122. Novartis AG Description and Major Businesses
    Table 123. Novartis AG DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Novartis AG DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Novartis AG Recent Developments
    Table 126. Seqirus Corporation Information
    Table 127. Seqirus Description and Major Businesses
    Table 128. Seqirus DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Seqirus DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Seqirus Recent Developments
    Table 131. Merck Sharp & Dohme Corp Corporation Information
    Table 132. Merck Sharp & Dohme Corp Description and Major Businesses
    Table 133. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Merck Sharp & Dohme Corp Recent Developments
    Table 136. Astellas Pharma US, Inc Corporation Information
    Table 137. Astellas Pharma US, Inc Description and Major Businesses
    Table 138. Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Astellas Pharma US, Inc DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Astellas Pharma US, Inc Recent Developments
    Table 141. Pfizer Inc Corporation Information
    Table 142. Pfizer Inc Description and Major Businesses
    Table 143. Pfizer Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. Pfizer Inc DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. Pfizer Inc Recent Developments
    Table 146. Johnson & Johnson Corporation Information
    Table 147. Johnson & Johnson Description and Major Businesses
    Table 148. Johnson & Johnson DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. Johnson & Johnson DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. Johnson & Johnson Recent Developments
    Table 151. Lanzhou Institute of Biological Products Co., Ltd Corporation Information
    Table 152. Lanzhou Institute of Biological Products Co., Ltd Description and Major Businesses
    Table 153. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Lanzhou Institute of Biological Products Co., Ltd DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Lanzhou Institute of Biological Products Co., Ltd Recent Developments
    Table 156. AstraZeneca Corporation Information
    Table 157. AstraZeneca Description and Major Businesses
    Table 158. AstraZeneca DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 159. AstraZeneca DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. AstraZeneca Recent Developments
    Table 161. Emergent BioSolutions Inc Corporation Information
    Table 162. Emergent BioSolutions Inc Description and Major Businesses
    Table 163. Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 164. Emergent BioSolutions Inc DTaP and Tdap Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Emergent BioSolutions Inc Recent Developments
    Table 166. Key Raw Materials Lists
    Table 167. Raw Materials Key Suppliers Lists
    Table 168. DTaP and Tdap Vaccines Distributors List
    Table 169. DTaP and Tdap Vaccines Customers List
    Table 170. DTaP and Tdap Vaccines Market Trends
    Table 171. DTaP and Tdap Vaccines Market Drivers
    Table 172. DTaP and Tdap Vaccines Market Challenges
    Table 173. DTaP and Tdap Vaccines Market Restraints
    Table 174. Research Programs/Design for This Report
    Table 175. Key Data Information from Secondary Sources
    Table 176. Key Data Information from Primary Sources
List of Figures
    Figure 1. DTaP and Tdap Vaccines Product Picture
    Figure 3. Global DTaP and Tdap Vaccines Market Share by Type in 2021 & 2028
    Figure 3. DTaP Product Picture
    Figure 4. Td Product Picture
    Figure 5. Tdap Product Picture
    Figure 6. Global DTaP and Tdap Vaccines Market Share by Application in 2021 & 2028
    Figure 7. Adult
    Figure 8. Pediatric
    Figure 9. DTaP and Tdap Vaccines Report Years Considered
    Figure 10. Global DTaP and Tdap Vaccines Sales 2017-2028 (K Units)
    Figure 11. Global DTaP and Tdap Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global DTaP and Tdap Vaccines Revenue 2017-2028 (US$ Million)
    Figure 13. Global DTaP and Tdap Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global DTaP and Tdap Vaccines Sales Market Share by Region (2017-2022)
    Figure 15. Global DTaP and Tdap Vaccines Sales Market Share by Region (2023-2028)
    Figure 16. North America DTaP and Tdap Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 17. North America DTaP and Tdap Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe DTaP and Tdap Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe DTaP and Tdap Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific DTaP and Tdap Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific DTaP and Tdap Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America DTaP and Tdap Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America DTaP and Tdap Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa DTaP and Tdap Vaccines Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa DTaP and Tdap Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The DTaP and Tdap Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of DTaP and Tdap Vaccines in the World: Market Share by DTaP and Tdap Vaccines Revenue in 2021
    Figure 28. Global DTaP and Tdap Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global DTaP and Tdap Vaccines Sales Market Share by Type (2017-2028)
    Figure 30. Global DTaP and Tdap Vaccines Revenue Market Share by Type (2017-2028)
    Figure 31. Global DTaP and Tdap Vaccines Sales Market Share by Application (2017-2028)
    Figure 32. Global DTaP and Tdap Vaccines Revenue Market Share by Application (2017-2028)
    Figure 33. North America DTaP and Tdap Vaccines Sales Market Share by Type (2017-2028)
    Figure 34. North America DTaP and Tdap Vaccines Revenue Market Share by Type (2017-2028)
    Figure 35. North America DTaP and Tdap Vaccines Sales Market Share by Application (2017-2028)
    Figure 36. North America DTaP and Tdap Vaccines Revenue Market Share by Application (2017-2028)
    Figure 37. North America DTaP and Tdap Vaccines Sales Share by Country (2017-2028)
    Figure 38. North America DTaP and Tdap Vaccines Revenue Share by Country (2017-2028)
    Figure 39. U.S. DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe DTaP and Tdap Vaccines Sales Market Share by Type (2017-2028)
    Figure 42. Europe DTaP and Tdap Vaccines Revenue Market Share by Type (2017-2028)
    Figure 43. Europe DTaP and Tdap Vaccines Sales Market Share by Application (2017-2028)
    Figure 44. Europe DTaP and Tdap Vaccines Revenue Market Share by Application (2017-2028)
    Figure 45. Europe DTaP and Tdap Vaccines Sales Share by Country (2017-2028)
    Figure 46. Europe DTaP and Tdap Vaccines Revenue Share by Country (2017-2028)
    Figure 47. Germany DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 48. France DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific DTaP and Tdap Vaccines Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific DTaP and Tdap Vaccines Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific DTaP and Tdap Vaccines Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific DTaP and Tdap Vaccines Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific DTaP and Tdap Vaccines Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific DTaP and Tdap Vaccines Revenue Share by Region (2017-2028)
    Figure 58. China DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. India DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America DTaP and Tdap Vaccines Sales Market Share by Type (2017-2028)
    Figure 69. Latin America DTaP and Tdap Vaccines Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America DTaP and Tdap Vaccines Sales Market Share by Application (2017-2028)
    Figure 71. Latin America DTaP and Tdap Vaccines Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America DTaP and Tdap Vaccines Sales Share by Country (2017-2028)
    Figure 73. Latin America DTaP and Tdap Vaccines Revenue Share by Country (2017-2028)
    Figure 74. Mexico DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa DTaP and Tdap Vaccines Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa DTaP and Tdap Vaccines Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa DTaP and Tdap Vaccines Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa DTaP and Tdap Vaccines Revenue Share by Country (2017-2028)
    Figure 83. Turkey DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE DTaP and Tdap Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 86. DTaP and Tdap Vaccines Value Chain
    Figure 87. DTaP and Tdap Vaccines Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi Pasteur
GlaxoSmithKline
Protein Sciences Corporation
Novartis AG
Seqirus
Merck Sharp & Dohme Corp
Astellas Pharma US, Inc
Pfizer Inc
Johnson & Johnson
Lanzhou Institute of Biological Products Co., Ltd
AstraZeneca
Emergent BioSolutions Inc
Frequently Asked Questions
DTaP and Tdap Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
DTaP and Tdap Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
DTaP and Tdap Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Rotavirus Vaccines

Rotavirus Vaccines market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More

Tetanus Vaccine

Tetanus Vaccine market is segmented by Type and by Application. Players, stakeholders, and other  ... Read More

TB Vaccines

TB Vaccines market is segmented by Type and by Application. Players, stakeholders, and other part ... Read More